STVN NYSE
Stevanato Group S.p.A.
1W: -0.5%
1M: +15.0%
3M: +11.5%
YTD: -13.0%
1Y: -26.2%
3Y: -34.5%
$18.01
+0.16 (+0.90%)
Weekly Expected Move ±5.6%
$16
$17
$18
$19
$20
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$4.9B
52W Range12.89-28
Volume173,542
Avg Volume566,266
Beta0.76
Dividend$0.06
Analyst Ratings
Company Info
CEOFranco Stevanato
Employees5,521
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2021-07-16
Websitestevanatogroup.com
Via Molinella, 17
Piombino Dese, PD 35017
IT
Piombino Dese, PD 35017
IT
39 04 99 31 811
About Stevanato Group S.p.A.
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.
Latest News
Stevanato (STVN) Q1 2026 Earnings Transcript
Stevanato maintains 2026 guidance of €1.260B-€1.290B revenue as it targets RTU cartridge production in early 2027
Stevanato Group (STVN) Q1 Earnings and Revenues Beat Estimates
Stevanato Group Non-GAAP EPS of €0.11
Madrigal (MDGL) Reports Q1 Loss, Beats Revenue Estimates
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Santel Luciano | 0 | — | 2026-03-18 | |
| Magistretti Elisabet | 0 | — | 2026-03-18 | |
| Flynn Karen | 0 | — | 2026-03-18 | |
| FEDERICI WILLIAM J | 0 | — | 2026-03-18 | |
| FEDERICI WILLIAM J | 0 | — | 2026-03-18 |